Upcoming updates
for 2026-2027
Ketamine and Esketamine: State of The Art – Interview
Tricyclic Antidepressants in Psychiatry: Part 2 – Safety and Management
Quick Take Vol. 86
Posttraumatic Stress Disorder Psychopharmacology Algorithm (Update)
Antidepressant-Induced Excessive Sweating
The Psychopharmacology of Adult ADHD: Focus on Women’s Issues – Interview
Quick Take Vol. 87
Side Effects of Antidepressants Part 5 (Hyperprolactinemia)
Prescribing Psychotropics in Medically Complex Patients: What Clinicians Need to Know
Antipsychotic Blood Levels in Practice – Interview
Quick Take Vol. 88
Cardiac Effects of Antidepressants: A Clinical Guide
Mood and Anxiety Disorders During Perimenopause – Interview
Nutraceuticals and Phytoceuticals for Mood and Anxiety Disorders
Quick Take Vol. 89
Ophthalmologic Effects of Antidepressants: A Clinical Guide
Pharmacotherapy for Cannabis Use Disorder
Updates on Geriatric Psychopharmacology – Interview
Lamotrigine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 90
Pharmacological Management of Primary Insomnia
Treatment-Resistant Obsessive-Compulsive Disorder (Update) – Interview
Valproate Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 91
Management of Psychotropic-Induced Sexual Dysfunction – Interview
Switching Antipsychotics in Clinical Practice 2026 update
Lithium Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 92
Buspirone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Pharmacotherapy of treatment-resistant depression – Interview
Cardiac Side Effects of Psychiatric Medications
Quick Take Vol. 93
Atomoxetine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Bipolar Disorder Pharmacotherapy – Interview
Pharmacotherapy of Borderline Personality Disorder (Second Edition)
Methylphenidate Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 94
Psychotropic-Induced Movement Disorders and Cognitive Side Effects – Interview
Bipolar Disorder in the Perinatal Period (2nd Edition)
Amphetamines Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 95
Pharmacotherapy Bipolar Depression: Strategies for Everyday Management – Interview
Psychopharmacology of Weight Gain and Obesity
ADHD Medications: A Comprehensive Formulations Guide
Quick Take Vol. 96
Brexpiprazole Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Antidepressant Withdrawal Effects and Safe Deprescribing – Interview
Drug-Drug Interactions in Psychopharmacology.
Quick Take Vol. 97
Cariprazine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Diagnosis and Management of Generalized Anxiety Disorder: Focus on Treatment-Resistant Cases
Addiction Psychopharmacology in Patients with Medical Comorbidities – Interview
CME Information
Physicians – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nursing professionals – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour.
Physician assistants – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Self Assessment for MOC – Accreditation Statement
- Psychopharmacology Institute Self-Assessment Program 2025
Dates: April 1, 2025 – April 1, 2028
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment Program 2024
Dates: April 1, 2024 – April 1, 2027
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.